Immunologic response of unvaccinated workers exposed to anthrax, Belgium

Emerging Infectious Diseases

Volumn 15, Issue 10, 2009, Pages 1637-1640

  Wattiau, Pierre ^a   Govaerts, Marc ^a   Frangoulidis, Dimitrios ^b   Fretin, David ^a   Kissling, Esther ^c,f   Van Hessche, Mieke ^a   China, Bernard ^c   Poncin, Martine ^d   Pirenne, Yvo ^e   Hanquet, Germaine ^c  

^a VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^b BUNDESWEHR INSTITUTE OF MICROBIOLOGY   (Germany)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^d Occupational Medicine PROVIKMO   (Belgium)

^e Medical Inspection   (Belgium)

^f EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN;

ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BELGIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GOAT; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; INDUSTRIAL WORKER; LYMPHOCYTE PROLIFERATION; SEROLOGY; T LYMPHOCYTE; WESTERN BLOTTING; WOOL;

ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; BACILLUS ANTHRACIS; BELGIUM; BLOTTING, WESTERN; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INHALATION EXPOSURE; OCCUPATIONAL EXPOSURE; T-LYMPHOCYTES;

EID: 70349976326     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1510.081717     Document Type: Article

References (15)

1. Brachman PS, Plotkin SA, Bumford FH, Atchisson MM. An epidemic of inhalation anthrax: the first in the twentieth century. II. Epidemiology. Am J Hyg. 1960;72:6-23.
2. Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A, et al. Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthrax. Euro Surveill. 2004;9:E3-4.
3. European Commission. Health and consummers directorate CPublic health and risk assessment. Cases of anthrax reported to EU, 1997-2006 [cited 2009 Aug 31]. Available from http://ec.europa.eu/ health/ph-information/dissemination/ echi/docs/anthrax-en.pdf
4. Kreidl P, Stifter E, Richter A, Aschbachert R, Nienstedt F, Unterhuber H, et al. Anthrax in animals and a farmer in Alto Adige, Italy. Euro Surveill. 2006;11:E060216-3.
5. Eurosurveillance Editorial Team. Probable human anthrax death in Scotland. Euro Surveill. 2006;11:E060817-2.
6. Van den Enden E, Van Gompel A, Van Esbroeck M. Cutaneous anthrax, Belgian traveler. Emerg Infect Dis. 2006;12:523-525
7. McCarthy M. Anthrax attack in the USA. Lancet Infect Dis. 2001;1:288-289 DOI: 10.1016/S1473-3099(01)00129-3
8. Wattiau P, Klee SR, Fretin D, Van Hessche M, Menart M, Franz T, et al. Occurrence and genetic diversity of Bacillus anthracis strains isolated in an active wool-cleaning factory. Appl Environ Microbiol. 2008;74:4005-4011 DOI: 10.1128/AEM.00417-08
9. Rosseels V, Marche S, Roupie V, Govaerts M, Godfroid J, Walravens K, et al. Members of the 30- to 32-kilodalton mycolyl transferase family (Ag85) from culture filtrate of Mycobacterium avium subsp. paratuberculosis are immunodominant Th1-type antigens recognized early upon infection in mice and cattle. Infect Immun. 2006;74:202-212 DOI: 10.1128/IAI.74.1.202-212.2006
10. Doolan DL, Freilich DA, Brice GT, Burgess TH, Berzins MP, Bull RL, et al. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics. J Infect Dis. 2007;195:174-184 DOI: 10.1086/510312
11. Norman PS, Ray JG Jr, Brachman PS, Plotkin SA, Pagano JS. Serologic testing for anthrax antibodies in workers in a goat hair processing mill. Am J Hyg. 1960;72:32-37
12. Grunow R, Porsch-Ozcurumez M, Splettstoesser W, Buckendahl A, Hahn U, Beyer W, et al. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine. Vaccine. 2007;25:3679-3683 DOI: 10.1016/j.vaccine.2007.01.056 (Pubitemid 46584757)
13. Zhang Y, Qiu J, Zhou Y, Farhangfar F, Hester J, Lin AY, et al. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses. Vaccine. 2008;26:614-622 DOI: 10.1016/j.vaccine.2007.11.072
14. Centers for Disease Control and Prevention. Vaccines and immunizations. [cited 2009 Aug 31]. Available from http://www.cdc.gov/ vaccines/vac-gen/side- effects.htm#anthrax.
15. Demicheli V, Rivetti D, Deeks JJ, Jefferson T, Pratt M. The effectiveness and safety of vaccines against human anthrax: a systematic review. Vaccine. 1998;16:880-884 DOI: 10.1016/S0264-410-X(98)00023-1 (Pubitemid 28275996)